Leerink Partnrs Has Pessimistic Outlook of WBA Q1 Earnings

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) – Equities researchers at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for Walgreens Boots Alliance in a research report issued on Tuesday, December 17th. Leerink Partnrs analyst M. Cherny now anticipates that the pharmacy operator will post earnings of $0.34 per share for the quarter, down from their prior estimate of $0.40. The consensus estimate for Walgreens Boots Alliance’s current full-year earnings is $1.53 per share. Leerink Partnrs also issued estimates for Walgreens Boots Alliance’s Q3 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.35 EPS, FY2025 earnings at $1.52 EPS, FY2026 earnings at $1.49 EPS, FY2027 earnings at $1.63 EPS and FY2028 earnings at $1.73 EPS.

Other analysts have also issued reports about the company. Royal Bank of Canada dropped their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a report on Wednesday, December 4th. Morgan Stanley reduced their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. UBS Group boosted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Truist Financial dropped their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Finally, TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $12.58.

Walgreens Boots Alliance Trading Down 3.6 %

NASDAQ WBA opened at $9.35 on Friday. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $27.05. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $8.08 billion, a P/E ratio of -0.93, a PEG ratio of 1.36 and a beta of 0.66. The business has a fifty day simple moving average of $9.33 and a 200 day simple moving average of $10.59.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.67 earnings per share.

Institutional Trading of Walgreens Boots Alliance

Several institutional investors have recently made changes to their positions in WBA. State Street Corp grew its holdings in Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after buying an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after acquiring an additional 3,329,857 shares in the last quarter. Thompson Siegel & Walmsley LLC increased its holdings in Walgreens Boots Alliance by 98.8% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after acquiring an additional 2,992,648 shares during the last quarter. Two Sigma Advisers LP purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth $24,226,000. Finally, Newport Trust Company LLC bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $31,028,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 10.70%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.